Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias

Eur Heart J Acute Cardiovasc Care. 2022 Nov 30;11(11):865-874. doi: 10.1093/ehjacc/zuac107.

Abstract

Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the population have led to an increasing number of cancer patients presenting with acute CV diseases. These events may be related to cancer itself or cancer treatment. Acute cardiac care specialists must be aware of these acute CV complications and be able to manage them. This may require an individualized and multidisciplinary approach. The management of acute coronary syndromes and acute pericardial diseases in cancer patients was covered in part 1 of a clinical consensus document. This second part focusses on acute heart failure, acute myocardial diseases, venous thromboembolic diseases and acute arrhythmias.

Keywords: Acute heart failure; Acute toxicity; Arrhythmia; Cancer; Cardiac implanted electronic devices (CIED); Cardiotoxicity; Myocarditis; Pulmonary embolism; Takotsubo syndrome; Venous thromboembolic disease.

Publication types

  • Consensus Statement

MeSH terms

  • Acute Coronary Syndrome* / complications
  • Acute Coronary Syndrome* / diagnosis
  • Acute Coronary Syndrome* / epidemiology
  • Arrhythmias, Cardiac / complications
  • Arrhythmias, Cardiac / therapy
  • Cardiomyopathies* / complications
  • Cardiovascular Diseases* / complications
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / therapy
  • Heart Failure* / complications
  • Heart Failure* / therapy
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / epidemiology
  • Neoplasms* / therapy
  • Risk Factors